1.Anesthetic Experience in Thorocoscopic Cryosurgery for Metastatic Lung Cancer: A case report.
Sam Hong MIN ; Choon Hak LIM ; Jee Yeon KIM ; Hye Won LEE ; Hae Ja LIM ; Suk Min YOON ; Seong Ho CHANG
Korean Journal of Anesthesiology 2005;48(6):663-665
Cryosurgery has been used to treat various nonresectable tumors, and although it is known to have great safety, and minimal morbidity, and mortality, we experienced unexpected hypothermia during thoracoscopic cryosurgery for metastatic lung cancer. Even though arrythmia and coagulopathy were absent in our case, it is possible to experience such complications in cases of long duration cryosurgery. We report out experience and include a brief discussion of the issues involved.
Arrhythmias, Cardiac
;
Cryosurgery*
;
Hypothermia
;
Lung Neoplasms*
;
Lung*
;
Mortality
2.2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias: Part 1
Seung Young ROH ; Sung Hwan KIM ; Yoon Nyun KIM ; Ju Youn KIM ; Jun KIM ; Tae Hoon KIM ; Gi Byoung NAM ; Kyoung Min PARK ; Hyoung Seob PARK ; Hui Nam PAK ; Eun Jung BAE ; Seil OH ; Namsik YOON ; Man Young LEE ; Youngjin CHO ; Yongkeun CHO ; Eun Sun JIN ; Tae Joon CHA ; Jong Il CHOI ; Yoo Ri KIM
International Journal of Arrhythmia 2018;19(2):36-62
Ventricular arrhythmias (VA) are a major cause of sudden cardiac death (SCD) in patients with known heart disease. Risk assessment and effective prevention of SCD are key issues in these patients. Implantable cardioverter defibrillator (ICD) insertion effectively treats sustained VA and reduces mortality in patients at high risk of SCD. Appropriate anti-arrhythmic drugs and catheter ablation reduce the VA burden and the occurrence of ICD shocks. In this guideline, authors have described the general examination and medical treatment of patients with VA. Medications and catheter ablation are also used as acute phase therapy for sustained VA.
Arrhythmias, Cardiac
;
Catheter Ablation
;
Catheters
;
Death, Sudden, Cardiac
;
Defibrillators
;
Heart Diseases
;
Humans
;
Mortality
;
Risk Assessment
;
Shock
3.Difference of QT Dispersion between Patients with Ischemic and Idiopathic Dilated Cardiomyopathy.
Gue Ru HONG ; Dae Jin JUN ; Jun Ho BAE ; Jun Ho SUK ; Jong Seon PARK ; Dong Gu SHIN ; Young Jo KIM ; Bong Sup SIM
Korean Circulation Journal 1999;29(5):492-497
BACKGROUND AND OBJECTIVES: QT dispersion (QTd) is defined as the difference between the maximum and minimum QT interval in any of the 12 leads of the surface ECG. QTd has been shown to reflect regional variations in ventricular repolarization. Ischemic dilated cardiomyopathy (DCM) may lead to more spatial and temporal dispersion in ventricular repolarization than idiopathic DCM. The purpose of this study was to determine the difference of QTd between patients who had ischemic and idiopathic DCM. MATERIALS AND METHODS: The study population included 30 patients with ischemic DCM and 30 with idiopathic DCM. All standard 12-lead ECGs were examined prospectively by two observers who were unware of the patient's details. RESULTS: QTd in ischemic DCM was significantly higher than that in idiopathic DCM (63+/-32 vs. 44+/-26 msec, p=0.012) and JTd in ischemic DCM was significantly higher than that in idiopathic DCM (48+/-21 vs. 36+/-22 msec, p=0.036). Results did not change when Bazett's QTc and JTc was substituted for QT (QTcd:69+/-33 vs. 52+/-28 p=0.039) and JT (JTcd:56+/-21 vs. 41+/-25 p=0.043). CONCLUSION: Ischemic DCM has increased spatial inhomogeneity of repolarization probably due to more regional myocardial damages compared with idiopathic DCM. The value of QT dispersion as an easily accessible, non-invasive method in predicting the risk of life threatening arrhythmia and overall mortality in patients with dilated cardiomyopathy must be confirmed in prospective trials.
Arrhythmias, Cardiac
;
Cardiomyopathy, Dilated*
;
Electrocardiography
;
Heart Failure
;
Humans
;
Mortality
;
Prospective Studies
4.The Continuous Monitoring of Oxygen Saturation During Fiberoptic Bronchoscopy.
Hyun Jae KANG ; Yeon Jae KIM ; Jae Hyun CHYUN ; Yun Kyung DO ; Byung Ki LEE ; Won Ho KIM ; Jae Yong PARK ; Tae Hoon JUNG
Tuberculosis and Respiratory Diseases 2002;52(4):385-394
BACKGROUND: Flexible fiberoptic bronchoscopy(FFB) has become a widely performed technique for diagnosing and managing pulmonary disease because of its low complication and mortality rate. Since the use of FFB in p atients with severely depressed cardiorespiratory function is increasing and hypoxemia during the FFB can induce significant cardiac arrhythmias, the early detection and adequate management of hypoxemia during FFB is clinically important. METHODS: To evaluate the necessity of the continuous monitoring of the oxygen saturation(SaO2) during the FFB, the SaO2 was continuously monitored from the finger tip using pulse oximetry before, during and after the FFB in 379 patiets. The patients were then divided into two groups, those with and without hypoxemia (SaO2<90%). The baseline pulmonary function data and the clinical characteristics of the two groups were compared. RESULTS: The mean baseline SaO2 was 96.9+/-2.85%. An SaO2<90% was recorded at some point in 62(16.4%) out of 379 patients, with 12 out of 62 experiencing this prior to the FFB, in 37 out of 62 during the FFB, and in 13 out of 62 after the FFB. No differences were observed in the smoking and sex distribution between those with and without hypoxemia. The mean age was older in those with hypoxemia than those without. Significant differences were observed in the mean baseline SaO2 and the mean time for the procedure between the two groups. The FEV1 was significantly lower in those with hypoxemia, and both the FVC and FEV1/FVC also tended to decrease in this group. Managing hypoxemia included deep breathing in 20 patients, a supplemental oxygen supply in 39 patients, and the abortion of the procedure in 3 patients. CONCLUSIONS: These results suggest that the continuous monitoring of th oxygen saturation is necessary during fiberoptic bronchoscopy, and it should be performed in patients with a depressed pulmonay function in order for the early detection and adequate management of hypoxemia.
Anoxia
;
Arrhythmias, Cardiac
;
Bronchoscopy*
;
Fingers
;
Humans
;
Lung Diseases
;
Mortality
;
Oximetry
;
Oxygen*
;
Respiration
;
Sex Distribution
;
Smoke
;
Smoking
5.Surgical Management for Chronic Atrial Fibrillation.
Gyung Hun KANG ; Chul Hwan KIM ; Byung Yeol KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(1):59-65
Atrial fibrillation is the most common of all cardiac arrhythmias. It is associated with significant morbidity and mortality and is frequently resistant to medical therapy. On the experimental and clinical study, the presence of macroreentrant circuits and the absence of either microreentrant circuits or evidence of atrial automaticity suggests that atrial fibrillation should be amenable to surgical ablation. The results of the maze III procedure are associated with a higher incidence of postoperative sinus rhythm, improved long-term sinus node function, fewer pacemaker requirements, less arrhythmia recurrence, and improved long-term atrial transport function. We had experienced 4 patients with chronic atrial fibrillation. For the first time, Hioki procedure had been performed in the first patient with ASD and atrial fibrillation, regular sinus rhythm showed on postoperative EKG, but junctional rhythm and bradycardia developed postoperative 3 years. The maze III procedure for the rest with mitral valvular disease and atrial fibrillation had been done, followed by regular sinus rhythm for 2 patients and atrial fibrillation for 1 patient, managed with amiodarone, on immediate postoperative state. Echocardiogram documented good contraction of right atrium and hardly contraction of left atrium for 2 patients with regular sinus rhythm postoperative 3 months.
Amiodarone
;
Arrhythmias, Cardiac
;
Atrial Fibrillation*
;
Bradycardia
;
Electrocardiography
;
Heart Atria
;
Humans
;
Incidence
;
Mortality
;
Recurrence
;
Sinoatrial Node
6.Amiodarone-Induced ARDS after MVR: A case report.
Gi Bok LEE ; Eung Joong KIM ; Hyun Keun CHEE ; Yoon Cheol SHIN
The Korean Journal of Thoracic and Cardiovascular Surgery 2002;35(8):594-598
Amiodarone is an iodinated benzofuran derivative that has been proved effective in the control of supraventricular and ventricular arrhythmias refractory to other antiarrhythmic drugs. In patients treated with amiodarone, subsequent surgical intervention is a common clinical scenario, but unfortunately we do not have definite data about complications due to amiodarone after cardiac surgery. Some reports have shown that amiodarone treatment can be associated with a state of alpha-adrenergic and beta-adrenergic receptor blockade, which requires more pacing and epinephrine infusion for perioperative hemodynamic support. And some reports have also identified a severe form of ARDS in patients on amiodarone therapy which was associated with siginificant morbidity and mortality. We exprienced a patient who expired after mitral valve replacement due to amiodarone-induced ARDS; therefore, we report this case with a brief literature.
Amiodarone
;
Anti-Arrhythmia Agents
;
Arrhythmias, Cardiac
;
Epinephrine
;
Hemodynamics
;
Humans
;
Mitral Valve
;
Mortality
;
Thoracic Surgery
7.Reoperations after Fontan Procedures.
Cheul LEE ; Yong Jin KIM ; Jeong Ryul LEE ; Joon Ryang RHO
The Korean Journal of Thoracic and Cardiovascular Surgery 2003;36(7):457-462
BACKGROUND: Surgical results of the Fontan procedures in patients with a single ventricle have improved. As the perioperative mortality continues to decline and late outcome is forthcoming, attention is now being directed toward late complications of the Fontan procedures. We retrospectively analyzed our experience with reoperations after Fontan procedures. MATERIAL AND METHOD: Between January 1988 and December 2002, 24 patients underwent reoperations after Fontan procedures. The median age at Fontan procedures and reoperation was 3.3 years and 9.2 years, respectively. Types of initial Fontan procedures were atriopulmonary connection (n=11), lateral tunnel Fontan (n=11), and extracardiac conduit Fontan (n=2). Indications for reoperation included atrioventricular valve regurgitation (n=7), atrial arrhythmia (n=8), Fontan pathway stenosis (n=7), residual right-to-left shunt (n=5), etc. RESULT: Procedures performed at reoperation included atrioventricular valve replacement (n=6), conversion to lateral tunnel Fontan (n=5), conversion to extracardiac conduit Fontan (n=3), cryoablation of arrhythmia circuit (n=7), etc. There was no operative mortality. There were 2 late deaths. Mean follow-up duration was 2.7+/-2.1 years. All patients except two were in NYHA class I at the latest follow-up. Among 8 patients with preoperative atrial arrhythmia, postoperative conversion to normal sinus rhythm was achieved in 7 patients. CONCLUSION: Reoperations after Fontan procedures could be achieved with low mortality and morbidity. Reoperation may lead to clinical improvement in patients with specific target conditions such as atrioventricular valve regurgitation, refractory atrial arrhythmia, or Fontan pathway stenosis, especially in patients with previous atriopulmonary connection.
Arrhythmias, Cardiac
;
Constriction, Pathologic
;
Cryosurgery
;
Follow-Up Studies
;
Fontan Procedure
;
Humans
;
Mortality
;
Reoperation
;
Retrospective Studies
8.Clinical observation of aortic dissection.
Byeong Ik JANG ; Jin Ho PARK ; Dong Ku SHIN ; Yeoung Jo KIM ; Bong Sup SHIM ; Hyun Woo LEE ; Su Hyen KIM ; Sung Sae HAN
Yeungnam University Journal of Medicine 1992;9(2):334-341
A clinical review of 34 cases of aortic dissection which were admitted to Yeungnam University hospital between March 1983 and April 1992. The results are as follows: 1. The peak incidence was in 5th, 6th decade and male to female ratio was 1.83:1. 2. The most common cause of aortic dissection was atherosclerosis and hypertension (79%). 3. The most common presenting symptom was pain (73%). but dyspnea, palpable mass, murmur, shock were also observed. 4. Abnormal electrocardiographic finding was myocardial ischemia in 6 cases, arrhythmia in 5 cases, LVH in 5 cases. 5. The X-ray findings showed abnormal aortic contour in 10 cases but normal X-ray finding was observed in 63% of DeBaKey Type III. 6. The most common diagnostic procedure was echocardiogram and abdominal Ultrasonography. 7. The mortality of all cases was 20%, operation mortality was 18% but no death of medically treatment in medical indication.
Arrhythmias, Cardiac
;
Atherosclerosis
;
Dyspnea
;
Electrocardiography
;
Female
;
Humans
;
Hypertension
;
Incidence
;
Male
;
Mortality
;
Myocardial Ischemia
;
Shock
;
Ultrasonography
9.The Attack of Ventricular Arrhythmia Caused by Low Potassium Level in Hemodialysis Patients.
Tae Hee KIM ; Jae Pil YUN ; Hyun Jung SOEK ; Won Seok YANG ; Soon Bae KIM ; Sang Koo LEE ; Jung Sik PARK ; Su Kil PARK
Korean Journal of Nephrology 2006;25(2):321-326
ESRD patients have higher cardiovascular mortality risk than the general population. Increased QT dispersion has been shown to be a risk factor for cardiac arrhythmia in chronic hemodialysis patients with diabetes or arterial disease. It is known that QT dispersion is significantly prolonged in postdialysis than in predialysis. It is associated with a decrease in serum potassium. During hemodialysis, serum potassium is decreased and QT dispersion increases. Therefore ventricular arrhythmia frequently occurs in the latter half of dialysis. We report 2 cases of ventricular arrhythmia caused by potassium removal during dialysis in chronic hemodialysis patients.
Arrhythmias, Cardiac*
;
Dialysis
;
Humans
;
Hypokalemia
;
Kidney Failure, Chronic
;
Mortality
;
Potassium*
;
Renal Dialysis*
;
Risk Factors
10.Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score.
Chen Ying HUNG ; Yu Cheng HSIEH ; Jin Long HUANG ; Ching Heng LIN ; Tsu Juey WU
Korean Circulation Journal 2014;44(4):205-209
Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased cardiovascular morbidity and mortality. The anti-arrhythmic effect of statins on AF prevention appears to be highly significant in most clinical studies. However, some discrepancies do exist among different clinical studies. Different clinical settings and types of stains used may explain these differences between trials. The CHADS2 and CHA2DS2VASc scoring systems have been used for stroke risk stratification in AF patients. The recent study suggested that these scores can also be used to guide statin therapy for AF prevention. Patients with higher scores had a higher risk of developing AF and gained more benefits from statins therapy than those with lower scores. This review article focused on the ability of these scores to predict AF prevention by statins.
Arrhythmias, Cardiac
;
Atrial Fibrillation*
;
Coloring Agents
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
;
Mortality
;
Primary Prevention*
;
Stroke